Even if clinical trials suggest tolerability, the real-world risk profile changes when: the source and purity of the peptide are uncertain, its used in different routes than studied, its used in stacked protocols with other drugs, its used in populations the trials didnt represent
[1] [3] The standard UK treatment involves hydroxocobalamin 1mg intramuscular injections, with dosing regimens typically consisting of initial loading doses (e.g., every other day for two weeks) followed by maintenance doses every 2-3 months for conditions like pernicious anaemia
This suggests its metabolic influence is primarily on fat oxidation rather than muscle catabolism
It was specifically engineered to isolate the fat-metabolizing properties of growth hormone without producing other systemic effects
The mix of an initial high dose and weekly shots for a month is a strong way to manage the deficiency
American Journal of Clinical Nutrition, 115(4), 787-789